Clinical Trial Update: Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating sunitinib in combination with cisplatin/capecitabine or oxaliplatin/capecitabine in advanced gastric cancer has completed. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Eloxatin (oxaliplatin)
• Sutent (sunitinib)
• Xeloda (capecitabine)

Snippet

Sponsor: Pfizer | Conditions: Stomach Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2011-09-05